These results further suggest that the TLR4 pathway might serve as a target for new anti-inflammatory treatments critically needed to not only control the explosive inflammation seen in B. cereus ocular infection, but also ocular infections due to Klebsiella pneumoniae and other Gram negative pathogens. The gene discussed is TLR4; the disease is eye infection.